Insider · CIK 0001243847

GREEN JOHN B

Reports to the SEC for 3 companies · FRAMINGHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001243847

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-04-20	Dicerna Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−25.6K sh	$22.95	−$588K	19,421
2020-04-20	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−25.6K sh	—	—	186,375
2020-04-20	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+25.6K sh	$5.45	+$140K	45,045
2020-04-07	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,501 sh	$5.45	+$40.9K	26,922
2020-04-07	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−13K sh	—	—	14,063
2020-04-07	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,501 sh	—	—	211,999
2020-04-07	Dicerna Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−20.5K sh	$19.95	−$408K	19,421
2020-04-07	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+13K sh	$2.97	+$38.5K	39,890
2020-01-17	Dicerna Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−27.5K sh	$21.27	−$585K	39,890
2020-01-17	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−27.5K sh	—	—	47,500
2020-01-17	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−20.5K sh	—	—	27,031
2020-01-17	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+27.5K sh	$2.97	+$81.7K	46,921
2020-01-17	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+20.5K sh	$2.97	+$60.8K	67,390
2020-01-17	Dicerna Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−20.5K sh	$21.26	−$435K	19,421
2020-01-08	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+85K sh	—	—	85,000
2020-01-08	Dicerna Pharmaceuticals IncRestricted Stock UnitsA Award	Chief Financial Officer	AAward	+23.1K sh	—	—	23,100
2019-12-11	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+8,000 sh	$5.45	+$43.6K	18,698
2019-12-11	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,000 sh	—	—	219,500
2019-11-25	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	227,500
2019-11-25	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	$5.45	+$68.1K	23,198
2019-11-25	Dicerna Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−12.5K sh	$24.95	−$312K	10,698
2019-11-18	Dicerna Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−12.5K sh	$21.05	−$263K	10,698
2019-11-18	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	$5.45	+$68.1K	23,198
2019-11-18	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	240,000
2019-11-14	Dicerna Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−3,562 sh	$20.00	−$71.2K	10,698
2019-10-31	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	$5.45	+$68.1K	26,760
2019-10-31	Dicerna Pharmaceuticals IncS Sale	Chief Financial Officer	SSale	−12.5K sh	$18.00	−$225K	14,260
2019-10-31	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	252,500
2019-01-02	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+180K sh	—	—	180,000
2017-01-03	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2016-04-14	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+265K sh	—	—	265,000
2016-01-01	VSTMVerastem, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+23.8K sh	—	—	23,760
2015-11-09	VSTMVerastem, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+48.2K sh	—	—	48,240
2015-06-29	VSTMVerastem, Inc.P Purchase	Chief Financial Officer	PPurchase	+500 sh	$7.12	+$3,560	2,500
2015-06-26	VSTMVerastem, Inc.P Purchase	Chief Financial Officer	PPurchase	+500 sh	$7.39	+$3,695.95	2,000
2015-01-08	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+44.5K sh	—	—	44,497
2014-12-23	VSTMVerastem, Inc.P Purchase	Chief Financial Officer	PPurchase	+500 sh	$8.17	+$4,085	1,500
2014-01-07	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	60,000
2013-06-03	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2009-11-02	rEVO Biologics, Inc.A Award	Senior VP and CFO	AAward	+13.7K sh	$1.21	+$16.6K	28,173
2009-11-02	rEVO Biologics, Inc.A Award	Senior VP and CFO	AAward	+15.5K sh	$1.21	+$18.8K	30,000
2009-11-02	rEVO Biologics, Inc.F Tax Payment	Senior VP and CFO	FTax Payment	−5,587 sh	$1.21	−$6,760.27	24,413
2009-06-30	rEVO Biologics, Inc.F Tax Payment	Senior VP and CFO	FTax Payment	−1,165 sh	$2.66	−$3,098.9	14,451
2009-03-30	rEVO Biologics, Inc.Stock Option (Right to Buy)A Award	Senior VP and CFO	AAward	+35K sh	—	—	35,000
2009-01-02	rEVO Biologics, Inc.A Award	Senior VP and CFO	AAward	+5,400 sh	—	—	156,170
2008-03-07	rEVO Biologics, Inc.Stock Option (Right to Buy)A Award	Senior VP and CFO	AAward	+25K sh	—	—	25,000
2008-03-07	rEVO Biologics, Inc.A Award	Senior VP and CFO	AAward	+33K sh	—	—	120,170
2007-05-23	rEVO Biologics, Inc.Stock Option (Right to Buy)A Award	Senior VP and CFO	AAward	+22.5K sh	—	—	22,500
2007-03-06	rEVO Biologics, Inc.Stock Option (Right to Buy)A Award	Senior VP and CFO	AAward	+22.5K sh	—	—	22,500
2006-08-10	rEVO Biologics, Inc.A Award	Senior VP and CFO	AAward	+1,000 sh	$1.23	+$1,230	85,700

Recent filings

Accepted (ET)
Apr 224
GREEN JOHN B0000899243-20-011186
SEC(opens sec.gov)
Apr 94
GREEN JOHN B0000899243-20-010623
SEC(opens sec.gov)
Jan 214
GREEN JOHN B0000899243-20-001539
SEC(opens sec.gov)
Jan 104
GREEN JOHN B0000899243-20-001032
SEC(opens sec.gov)
Dec 114
GREEN JOHN B0000899243-19-028981
SEC(opens sec.gov)
Nov 274
GREEN JOHN B0000899243-19-028270
SEC(opens sec.gov)

Companies

Address

C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702